Tofacitinib in a case of generalized granuloma annulare: A two-year follow-up of relapse and remission
Year: 2024
Type: article
Study design: Case Report
Abstract: Recent research into the immunopathogenesis of granuloma annulare (GA) has led to new treatments.We share our experience with tofacitinib, a Janus Kinase/signal transducer and activator of transcription (JAK/STAT) inhibitor, in a biopsy-proven case of generalized GA (GGA) over two years of follow-up.www.cosmoderma.org
Source: Cosmoderma
Authors: Shruthi Pavana Janardhanan, Punit Saraogi
Language: English
Topic: Skin Diseases and Diabetes
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4402997520